Ulinastatin Reduces the Resistance of Liver Cancer Cells to Epirubicin by Inhibiting Autophagy

During chemotherapy, drug resistance caused by autophagy remains a major challenge to successful treatment of cancer patients. The purpose of this study is to show that ulinastatin (UTI), a trypsin inhibitor, could reduce the resistance of liver cancer cells to chemotherapeutic agent epirubicin (EPI...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Bin, Bian, Qi, Shao, Cheng Hao, Li, Gang, Liu, An An, Jing, Wei, Liu, Rui, Zhang, Yi-Jie, Zhou, Ying-Qi, Hu, Xian-Gui, Jin, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376693/
https://www.ncbi.nlm.nih.gov/pubmed/25815885
http://dx.doi.org/10.1371/journal.pone.0120694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376693/
https://www.ncbi.nlm.nih.gov/pubmed/25815885
http://dx.doi.org/10.1371/journal.pone.0120694

Ejemplares similares